Literature DB >> 10095100

Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector.

C A Strathdee1, M R McLeod, J R Hall.   

Abstract

The tetracycline-responsive expression system is based on the ability of the chimeric tTA and rtTA transactivators to stimulate specifically transcription from a companion synthetic CMV* or TK* promoter element, and can provide tightly regulated gene expression that can be induced up to five orders of magnitude in cultured cells and transgenic mice. A major problem with the system is that high level expression of the tTA or rtTA transactivators causes cellular toxicity. Under conditions of prolonged expression this results in selective pressure against the stable incorporation of vectors expressing the tTA or rtTA transactivators, and makes the generation of stable cell lines and transgenic mice problematic. In this report we describe the development of a set of autoregulated bi-directional expression vectors in which the weaker TK* promoter is used to direct expression of the rtTA or tTA transactivator and the stronger CMV* element is used to direct cDNA expression. In this format the transactivator and response elements are encoded on the same vector, which simplifies the system and ensures that gene expression is effectively skewed in favor of the cDNA while maintaining a continuously low level of transactivator expression. We find that such an autoregulated system works equally well for both the tTA and rtTA transactivators, provided that they contain a nuclear localization signal. Similar to other versions of the tetracycline-responsive expression system, gene expression is tightly regulated and can be efficiently switched between the off and on expression states by doxycycline. In contrast with other tetracycline-responsive systems, however, expression of the rtTA and tTA transactivators from the autoregulated TK* promoter is low enough such that there is no cellular toxicity associated with either expression state. By incorporating a selectable marker into these vectors, all of the components required for using the system are now contained on a single plasmid construct, and we find that this format provides a more reliable and greatly simplified method for the generation of stable cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095100     DOI: 10.1016/s0378-1119(99)00045-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  42 in total

1.  Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual.

Authors:  Rachel A Davey; Michele V Clarke; Stephen Sastra; Jarrod P Skinner; Cherie Chiang; Paul H Anderson; Jeffrey D Zajac
Journal:  Transgenic Res       Date:  2011-12-13       Impact factor: 2.788

2.  Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation.

Authors:  Xiaohua Su; Sei Kameoka; Susan Lentz; Sadhan Majumder
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

3.  Conversion of myoblasts to physiologically active neuronal phenotype.

Authors:  Yumi Watanabe; Sei Kameoka; Vidya Gopalakrishnan; Kenneth D Aldape; Zhizhong Z Pan; Frederick F Lang; Sadhan Majumder
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

4.  Studying the effects of actin cytoskeletal destabilization on cell cycle by cofilin overexpression.

Authors:  Yi-Jang Lee; Peter C Keng
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

Review 5.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

6.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

Review 7.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

8.  A novel loop domain in superantigens extends their T cell receptor recognition site.

Authors:  Sebastian Günther; Ashok K Varma; Beenu Moza; Katherine J Kasper; Aaron W Wyatt; Penny Zhu; A K M Nur-ur Rahman; Yili Li; Roy A Mariuzza; John K McCormick; Eric J Sundberg
Journal:  J Mol Biol       Date:  2007-05-18       Impact factor: 5.469

9.  Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.

Authors:  Kelly L Sudol; Michael A Mastrangelo; Wade C Narrow; Maria E Frazer; Yona R Levites; Todd E Golde; Howard J Federoff; William J Bowers
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

10.  CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA.

Authors:  Young-Hwa Goo; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.